Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$545M |
| 2 |
Danaher
DHR
|
+$429M |
| 3 |
PayPal
PYPL
|
+$426M |
| 4 |
XYZ
Block Inc
XYZ
|
+$397M |
| 5 |
Intuitive Surgical
ISRG
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$724M |
| 2 |
McDonald's
MCD
|
+$704M |
| 3 |
UnitedHealth
UNH
|
+$675M |
| 4 |
JPMorgan Chase
JPM
|
+$570M |
| 5 |
Booking.com
BKNG
|
+$559M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.98% |
| 2 | Healthcare | 17.07% |
| 3 | Consumer Discretionary | 16.52% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 11.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEMG
426
DELISTED
SEMGROUP CORPORATION
SEMG
| $9.63M | 0.01% |
653,071
-488,161
| -43% | -$7.72M |
|
427
Emergent Biosolutions
EBS
$373M
| $9.56M | 0.01% |
+189,264
| New | +$11.2M |
|
428
Chemours
CC
$2.5B
| $9.53M | 0.01% |
256,363
+332
| +0.1% | +$12.1K |
|
429
Constellium
CSTM
$3.76B
| $9.18M | 0.01% |
1,150,603
+237,285
| +26% | +$2.03M |
|
430
Wheaton Precious Metals
WPM
$49.5B
| $9.09M | 0.01% |
381,467
-549
| -0.1% | -$11.7K |
|
431
Sunrun
RUN
$2.34B
| $9.07M | 0.01% |
644,937
-227,492
| -26% | -$3.13M |
|
432
Select Water Solutions
WTTR
$2.3B
| $9.07M | 0.01% |
754,273
+63,653
| +9% | +$599K |
|
|
NBLX
433
DELISTED
Noble Midstream Partners LP
NBLX
| $9.06M | 0.01% |
251,683
+2,465
| +1% | +$84.1K |
|
434
CME Group
CME
$96.3B
| $8.95M | 0.01% |
54,403
-134,631
| -71% | -$23.8M |
|
435
TC Energy
TRP
$70.2B
| $8.88M | 0.01% |
197,547
+190,073
| +2,543% | +$8.17M |
|
|
SAND
436
DELISTED
Sandstorm Gold
SAND
| $8.82M | 0.01% |
+1,608,895
| New | +$8.49M |
|
|
EPZM
437
DELISTED
Epizyme, Inc
EPZM
| $8.8M | 0.01% |
710,156
-1,166,839
| -62% | -$13M |
|
|
RUBY
438
DELISTED
Rubius Therapeutics, Inc
RUBY
| $8.68M | 0.01% |
479,398
+1,802
| +0.4% | +$27.7K |
|
439
BrightView Holdings
BV
$1.22B
| $8.63M | 0.01% |
599,461
-287,820
| -32% | -$4M |
|
440
Fate Therapeutics
FATE
$286M
| $8.56M | 0.01% |
487,044
+253,540
| +109% | +$4M |
|
|
ARYAU
441
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $8.47M | 0.01% |
818,849
-10,664
| -1% | -$111K |
|
|
CEQP
442
DELISTED
Crestwood Equity Partners LP
CEQP
| $8.38M | 0.01% |
238,039
+2,325
| +1% | +$75.3K |
|
443
Thermo Fisher Scientific
TMO
$213B
| $8.34M | 0.01% |
30,452
-84,728
| -74% | -$21.1M |
|
|
PXD
444
DELISTED
Pioneer Natural Resource Co.
PXD
| $8.32M | 0.01% |
54,617
-40,955
| -43% | -$5.78M |
|
|
ANDX
445
DELISTED
Andeavor Logistics LP
ANDX
| $8.26M | 0.01% |
234,324
+2,329
| +1% | +$82.6K |
|
|
SEI
446
Solaris Energy Infrastructure
SEI
$3.15B
| $8.13M | 0.01% |
494,680
-543
| -0.1% | -$8.33K |
|
447
Devon Energy
DVN
$52.1B
| $8.03M | 0.01% |
254,454
-386,626
| -60% | -$10.8M |
|
448
Warrior Met Coal
HCC
$4.19B
| $7.91M | 0.01% |
260,207
-552
| -0.2% | -$15.1K |
|
449
Arcosa
ACA
$7.13B
| $7.89M | 0.01% |
258,435
-219,443
| -46% | -$6.7M |
|
|
CHX
450
DELISTED
ChampionX
CHX
| $7.68M | 0.01% |
+187,056
| New | +$6.92M |
|
Similar funds
Jennison Associates's Q1 2019 Portfolio in Review
As of Q1 2019, Jennison Associates held 723 positions worth $101B, up 13% from $89.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Jennison Associates withdrew a net $3.72B in Q1 2019, closing 96 positions and reducing 294 holdings. Its most notable exit was Booking.com, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Danaher worth $490M.
- Jennison Associates's largest Q1 2019 buy was Danaher: 4,186,042 shares worth $490M.
- Jennison Associates added most to lululemon athletica in Q1 2019, an estimated $545M increase.
- Jennison Associates's biggest Q1 2019 reduction was Goldman Sachs, cutting an estimated $724M.
- Jennison Associates fully exited Booking.com in Q1 2019, selling an estimated $559M.
- Jennison Associates's ten largest holdings make up 31% of its $101B portfolio in Q1 2019.
- Jennison Associates opened 83 new positions and closed 96 in Q1 2019.
- Jennison Associates's portfolio value rose 13% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q1 2019, filed 10 May 2019.